Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early and Long-term Clinical Efficacy and Local Tissue and Peripheral Immune Changes Following Dupilumab Treatment in Prurigo Nodularis Patients

NCT07276425 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT07276425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07276425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early and Long-term Clinical Efficacy and Local Tissue and Peripheral Immune Changes Following Dupilumab Treatment in Prurigo Nodularis Patients
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
June 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prurigo nodularis (pn)